IPIC is under heavy distribution and right now is even overbought in the short term (using 8 day TSV, OBV and stochastics) BOP an CMS (from worden's bro) are severely negative.
And this is not good either:
BOSTON, Oct. 9 /PRNewswire/ -- The following is being issued by the law
firm of Gilman and Pastor on behalf of persons who purchased Interneuron
Pharmaceuticals, Inc. ("INP") common stock during the period of March 1, 1997
through September 12, 1997 (the "Class Period"):
You are hereby notified that a class action has been commenced in the
United States District Court for the District of Massachusetts, Civil Action
No. 97-12254REK on behalf of all purchasers of INP common stock during the
Class Period, which asserts claims under the federal securities laws.
The complaint alleges that INP and certain individual officers and
directors of INP publicly disseminated materially false and misleading
statements concerning the prospects and safety of its only commercially
salable drug Redux (dexfenfluramine) which resulted in the artificial
inflation of the stock price for INP common stock during the Class Period.
Plaintiff seeks to recover damages suffered by class members who purchased INP
stock at artificially inflated prices as a result of defendants' unlawful
conduct.
If you purchased shares of INP common stock during the Class Period, you
may, not later than sixty days from the date of this notice (October 9, 1997),
move the Court to serve as lead plaintiff of the Class. To serve as lead
plaintiff, however, you must meet certain legal requirements. If you have any
questions regarding this Notice, the lawsuit, or your rights and interests,
please contact Edward L. Manchur or Peter A. Lagorio, of Gilman and Pastor, at
One Boston Place, Boston, Massachusetts 02108, by telephone 617-589-3750 or by
facsimile 617-589-3749.
Gilman and Pastor concentrates in securities, consumer protection and
other class action litigation, and has successfully represented many defrauded
investors and consumers.
SOURCE Gilman and Pastor
CONTACT: Edward L. Manchur or Peter A. Lagorio of Gilman and
Pastor, 617-589-3750
I used to be an owner at that time but I think I do not qualified since I did exit at small profit.
I think that the posibility of decline to the $6-5 range is there.
Recently in Investor's Businees Daily Senator Kennedy got bad press due to his apparently pro IPIC moves and the incoming new FDA regulations.
At least, Kennedy is on your side. |
